Literature DB >> 9184241

Multiple epiphyseal dysplasia and pseudoachondroplasia due to novel mutations in the calmodulin-like repeats of cartilage oligomeric matrix protein.

S Susic1, J McGrory, J Ahier, W G Cole.   

Abstract

A child with a mild form of pseudoachondroplasia was heterozygous for a deletion of 12 nucleotides from exon 10 of the cartilage oligomeric matrix protein (COMP) gene. It resulted in the deletion of valine 513 to lysine 516 from the eighth calmodulin-like repeat of COMP monomers. A child with the Fairbank's type of multiple epiphyseal dysplasia was also heterozygous for a COMP mutation. It substituted cysteine 371 by serine in the fourth calmodulin-like repeat. Both mutations were likely to alter the conformation and calcium binding of the mutant COMP protein chains. These findings support the proposal that deletions and insertions within the calmodulin-like domain produce pseudoachondroplasia, while amino acid substitutions with this domain may produce either pseudoachondroplasia or multiple epiphyseal dysplasia.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9184241     DOI: 10.1111/j.1399-0004.1997.tb02458.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  12 in total

1.  Identification of disease-specific genes in chronic pancreatitis using DNA array technology.

Authors:  H Friess; J Ding; J Kleeff; Q Liao; P O Berberat; J Hammer; M W Büchler
Journal:  Ann Surg       Date:  2001-12       Impact factor: 12.969

2.  Granulin epithelin precursor: a bone morphogenic protein 2-inducible growth factor that activates Erk1/2 signaling and JunB transcription factor in chondrogenesis.

Authors:  Jian Q Feng; Feng-Jin Guo; Bai-Chun Jiang; Yan Zhang; Sally Frenkel; Da-Wei Wang; Wei Tang; Yixia Xie; Chuan-Ju Liu
Journal:  FASEB J       Date:  2010-02-02       Impact factor: 5.191

3.  COL9A3: A third locus for multiple epiphyseal dysplasia.

Authors:  P Paassilta; J Lohiniva; S Annunen; J Bonaventure; M Le Merrer; L Pai; L Ala-Kokko
Journal:  Am J Hum Genet       Date:  1999-04       Impact factor: 11.025

4.  Identification of novel pro-alpha2(IX) collagen gene mutations in two families with distinctive oligo-epiphyseal forms of multiple epiphyseal dysplasia.

Authors:  P Holden; E G Canty; G R Mortier; B Zabel; J Spranger; A Carr; M E Grant; J A Loughlin; M D Briggs
Journal:  Am J Hum Genet       Date:  1999-07       Impact factor: 11.025

5.  A mutation in COL9A1 causes multiple epiphyseal dysplasia: further evidence for locus heterogeneity.

Authors:  M Czarny-Ratajczak; J Lohiniva; P Rogala; K Kozlowski; M Perälä; L Carter; T D Spector; L Kolodziej; U Seppänen; R Glazar; J Królewski; A Latos-Bielenska; L Ala-Kokko
Journal:  Am J Hum Genet       Date:  2001-09-14       Impact factor: 11.025

Review 6.  Progranulin: a promising therapeutic target for rheumatoid arthritis.

Authors:  Chuan-ju Liu
Journal:  FEBS Lett       Date:  2011-05-04       Impact factor: 4.124

Review 7.  Pseudoachondroplastic dysplasia: an Iowa review from human to mouse.

Authors:  J W Stevens
Journal:  Iowa Orthop J       Date:  1999

8.  ADAMTS-7: a metalloproteinase that directly binds to and degrades cartilage oligomeric matrix protein.

Authors:  Chuan-Ju Liu; Wei Kong; Kiril Ilalov; Shuang Yu; Ke Xu; Lisa Prazak; Marc Fajardo; Bantoo Sehgal; Paul E Di Cesare
Journal:  FASEB J       Date:  2006-04-03       Impact factor: 5.191

9.  ADAMTS-7, a direct target of PTHrP, adversely regulates endochondral bone growth by associating with and inactivating GEP growth factor.

Authors:  Xiao-Hui Bai; Da-Wei Wang; Li Kong; Yan Zhang; Yi Luan; Tatsuya Kobayashi; Henry M Kronenberg; Xiu-Ping Yu; Chuan-Ju Liu
Journal:  Mol Cell Biol       Date:  2009-06-01       Impact factor: 4.272

10.  Mutation (D472Y) in the type 3 repeat domain of cartilage oligomeric matrix protein affects its early vesicle trafficking in endoplasmic reticulum and induces apoptosis.

Authors:  Yusuke Hashimoto; Takami Tomiyama; Yoshiki Yamano; Hiroshi Mori
Journal:  Am J Pathol       Date:  2003-07       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.